Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Long-Term Debt Repayments (2019 - 2025)

Rockwell Medical's Long-Term Debt Repayments history spans 12 years, with the latest figure at $198000.0 for Q4 2025.

  • For Q4 2025, Long-Term Debt Repayments fell 1.49% year-over-year to $198000.0; the TTM value through Dec 2025 reached $664000.0, up 2.79%, while the annual FY2025 figure was $664000.0, 2.79% up from the prior year.
  • Long-Term Debt Repayments reached $198000.0 in Q4 2025 per RMTI's latest filing, roughly flat from $198000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $6.3 million in Q3 2022 to a low of -$5.3 million in Q4 2022.
  • Average Long-Term Debt Repayments over 5 years is $280937.5, with a median of $201000.0 recorded in 2024.
  • Peak YoY movement for Long-Term Debt Repayments: crashed 5745.74% in 2022, then soared 6800.0% in 2024.
  • A 5-year view of Long-Term Debt Repayments shows it stood at $94000.0 in 2021, then plummeted by 5745.74% to -$5.3 million in 2022, then soared by 109.27% to $492000.0 in 2023, then crashed by 59.15% to $201000.0 in 2024, then fell by 1.49% to $198000.0 in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Long-Term Debt Repayments are $198000.0 (Q4 2025), $198000.0 (Q3 2025), and $67000.0 (Q2 2025).